Background and Aim: Impaired gut-liver axis is a potential factor contributing to alcoholic liver disease. Ethanol depletes intestinal integrity and causes gut dysbiosis. Butyrate, a fermentation byproduct of gut microbiota, is altered negatively following chronic ethanol exposure. This study aimed to determine whether prophylactic tributyrin could protect the intestinal barrier and liver in mice during combined chronic-binge ethanol exposure. Methods: C57BL/6J mice exposed to 5% v/v ethanol-containing diet for 10 days received a single ethanol gavage (5 g/kg) 9 h before euthanasia. Control mice were isocalorically pair-fed maltose dextrin for ethanol. Diets were supplemented (5 mM) with tributyrin or glycerol. Intestine and liver disease activity was assessed histologically. Protein and mRNA expression of tight junction (TJ) proteins, toll-like receptors, and tumor necrosis factor-alpha were assessed. Caco-2 monolayers with or without ethanol exposure and/or sodium butyrate were used to test butyrate's direct effects on intestinal integrity. Results: Chronic-binge ethanol feeding impaired intestinal TJ protein co-localization staining; however, tributyrin co-treatment mitigated these effects. Ethanol depleted TJ and transepithelial electrical resistance in Caco-2 monolayers, but butyrate co-treatment reduced these effects. Hepatic toll-like receptor mRNA expression and tumor necrosis factor-alpha protein expression was induced by ethanol; however, the response was significantly dampened in mice co-treated with tributyrin. Tributyrin altered localization of both neutrophils and single hepatocyte death: Leukocytes and apoptotic hepatocytes localized predominantly around the portal tract in ethanol-only treated mice, whereas localization predominated around the central vein in ethanol-tributyrin mice. Conclusions: Prophylactic tributyrin supplementation mitigated effects of combined chronic-binge ethanol exposure on disruption of intestinal TJ localization and intestinal permeability and liver injury.
Introduction
Alcoholic hepatitis (AH) is a syndrome of progressive inflammatory liver injury associated with chronic ethanol intake. An unclear triggering event is responsible for initiation of steatohepatitis in those with hepatic steatosis that continue to consume alcohol. 1 Gut dysbiosis and intestinal permeability are among multiple potential implicated triggers. [2] [3] [4] [5] [6] Animals and humans exposed to ethanol chronically exhibit overgrowth of opportunistic pathogenic and depletion of beneficial gut bacteria. [3] [4] [5] [6] Gut dysbiosis is concerning because the gut microbiota-host mutualistic relationship is disrupted, potentially jeopardizing benefits that this relationship provides including metabolism, host immunity, and barrier protection.
Undigested dietary polysaccharides are fermented to yield shortchain fatty acids (SCFA) with acetate, propionate, and butyrate predominating in the distal intestine in a nearly constant molar ratio of 60:25:15, respectively. 7 Butyrate, highly important for colonic health, can reach concentrations up to 20 mM in the colon and feces of mammals with normal gut health. 7, 8 As butyrate is the primary energy source for colonic mucosal enterocytes, 9 molar ratios of butyrate in circulation are comparatively lower than propionate and acetate at physiologic conditions. 10 Butyrate inhibits histone deacetylase and can influence gene expression. 11 Butyrate affects several cellular functions like proliferation and differentiation, increasing normal colonic epithelium proliferation but decreasing neoplastic colonocyte proliferation in vitro and in vivo. [11] [12] [13] Ethanol causes intestinal barrier impairment and bacterial translocation to the liver; however, underlying mechanisms remain unknown. After being metabolized to acetaldehyde, ethanol is rapidly converted to acetate in the liver and extrahepatic tissues.
In humans, 70-80% of oxidized ethanol appears as free acetate in the hepatic vein. 15 Circulating acetate can be transported into the intestinal lumen via monocarboxylate transporters. 16 High-dose ethanol-induced gut dysbiosis is associated with non-physiologic ratios of SCFA in the intestine with elevated luminal acetate levels but significantly lower butyrate concentrations in the distal intestine. 17 Higher acetate-to-butyrate ratios are associated with increased colonic pathology. 18, 19 Absence of butyrate in intestinal tissue is associated with apoptosis and inflammation, 11, 20 and mucosal atrophy, which is reversible in the presence of butyrate. 7, 11, 18, 21 We hypothesized that skewed SCFA ratios induced by ethanol exposure contribute to decreased intestinal integrit and, increased epithelial cell permeability and promote liver inflammation. This study investigated tributyrin's role in protecting intestinal integrity and consequent liver injury in a combined chronic-binge ethanol mouse model of early stage AH.
Methods
Materials. Glyceryl tributyrate (tributyrin), sodium butyrate came from Sigma-Aldrich (St. Louis, MO, USA). Pair-fed control diet and Lieber-DeCarli high-fat ethanol diet came from Dyets, Inc (Bethlehem, PA, USA). All primers for quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) were synthesized by Integrated DNA Technologies (Coralville, IA, USA). Primary antibodies came from the following: anti-occludin (Hycult Biotech, Plymouth Meeting, PA, USA); anti-tumor necrosis factor-alpha (TNF-α; Fitzgerald Industries International, Acton, MA, USA); anti-zonula occluden-1 (Abcam Cambridge, MA, USA); anti-claudin-3 (Invitrogen, Carlsbad, CA, USA).
Methods. Female C57BL/6J mice (8-10 weeks old) were purchased from Jackson Laboratories (Bar Harbor, ME, USA). Animals were housed in standard microisolator cages (two animals per cage) and fed standard laboratory chow (rodent diet #2918, Harlan-Teklad, Madison, WI, USA) before initiation of liquid diet feeding. All animal procedures were approved by Institutional Animal Care and Use Committee.
Chronic-binge ethanol feeding and tributyrin provision. Weight-matched animals were randomly assigned so that each treatment group was within 0.5 gm of each other and then adapted to a control liquid diet for 5 days and allowed either ad libitum access to a 5% v/v (27% total kcal) ethanol-containing diet or pair-fed a diet that isocalorically substituted maltose dextrin for ethanol for 10 days. Diets were made fresh every other day and supplemented with tributyrin (5 mM) or glycerol (5 mM) over the 10 days of ethanol feeding. On day 11, mice were gavaged with a 5-g/kg dose of ethanol or isocaloric maltose. 22 Included in the gavage at a concentration of 2.5 mM was either tributyrin (7.5 mg) or glycerol (2.3 mg).
At 9-h post-gavage, mice were anesthetized and blood was collected from the posterior vena cava by syringe and expelled into EDTA-containing tubes. Livers were weighed and portions fixed in formalin, frozen in optimal cutting temperature medium (Sakura Finetek USA, Torrance,CA, USA), snap frozen in liquid nitrogen, or stored in RNAlater (Ambion, Austin, TX, USA) for further analysis. Plasma was separated from whole blood and stored at À80°C. The intestine was dissected and frozen in optimal cutting temperature, snap frozen in liquid nitrogen, or stored in RNAlater.
Histopathology and immunohistochemistry
Histopathology of the proximal colon. Frozen proximal colon sections frozen in optimal cutting temperature (OCT) compound were stained with hematoxylin and eosin for histological observation under an Olympus BX41 light microscope with 100× magnification (10 × 10). Slides were coded before examination and were evaluated by a single pathologist blinded to treatment. Villus tip-to-crypt depth was measured, and mucosal damage was scored as follows 23 : Grade 0: normal structure of intestinal mucosa; Grade 1: subepithelial gap broadened at the apex of the villus, accompanied by capillary blood congestion; Grade 2: subepithelial gap further broadened and epithelial layers separated from the lamina propria; Grade 3: multiple epithelial layers separated from both sides of villi and a few villi exfoliated; Grade 4: lamina propria exposed because of many exfoliated villi; Grade 5: lamina propria digested and disintegrated, leading to ulceration. Results represent the average of 5-10 crypt lengths per section of tissue. Goblet cells in sections were counted. Ten crypts of intestinal villus in each section were selected and at least three sections per animal were evaluated.
Frozen intestinal sections in OCT were used for immunostaining of tight junction (TJ) proteins (claudin-3, occludin, ZO-1). Paraffin-embedded liver sections were deparaffinized and stained with hematoxylin and eosin or TNF-α and then studied by light microscopy. No specific immunostaining was seen in sections incubated with phosphate-buffered saline (PBS) rather than the primary antibody. Slides were coded before examination, and a single investigator blinded to treatments viewed them. All images presented represent at least three images per tissue section and four to six mice per experimental condition. Semi-quantification of positive staining was performed using ImagePro plus software (Media Cybernatics, Silver Spring, MD, USA).
Caco-2 cell culture. The human colonic epithelial cell line Caco-2 (ATTC, Manassas, VA, USA), a gift from Dr. Christine McDonald, was maintained in Dulbecco's modified Eagle's medium (Gibco BRL Products, Grand Island, NY, USA) supplemented with 4.5-g/L glucose, 10% fetal bovine serum (Invitrogen/Gibco), 1% nonessential amino acids, and 1% antibiotic solution (penicillin G, streptomycin B; Gibco BRL Products, Grand Island, NY, USA). Cells were grown in 75-cm 2 T-flasks (Fisher, St. Louis, MO, USA) at 37°C/5% CO 2 . The medium was changed three times weekly, and cells were passaged every 7 to 10 days. Cells were used within four passages of each other for this experiment.
Confluent monolayers were harvested by washing the cells with PBS followed by trypsin-EDTA solution. Caco-2 cells were seeded at 1 × 10 5 density into the apical chamber of a two-chamber cell culture system (Costar Corp., Cambridge, MA, USA) containing a 0.4-cm 2 pore size polycarbonate membrane or into a 24-well plate containing a sterile glass coverslip. Media were changed every 3 days, and the cell monolayer allowed to differentiate and polarize over 18-21 days. Cells were pretreated with sodium butyrate (5 mM) in the apical chamber or on glass coverslips for 18 h followed by challenge with ethanol (40 mM) for 3 h. Caco-2 monolayers seeded on glass coverslips were then rinsed with PBS and fixed with ice-cold methanol followed by immunostaining for TJ proteins.
Measurement of transepithelial electrical resistance. Determination of epithelial barrier function of Caco-2 cell monolayer and integrity of TJs formed between polarized cells was assessed by measurements of transepithelial electrical resistance (TEER) using a EVOM2, Epithelial Volt/Ohm Meter (World Precision Instruments, Sarasota, FL, USA) as previously described. 26 Briefly, cells were rinsed with room temperature PBS after which an average of three measurements per transwell were recorded. Experiments were performed in triplicate and repeated three times.
Biochemical assays. Plasma samples from at least four to six mice per experimental condition were assayed for alanine aminotransferase (ALT) and aspartate aminotransferase using commercially available enzymatic assay kits (Sekisui Diagnostics, Lexington, MA, USA) following manufacturer's instructions. Total hepatic triglycerides were assayed using the Triglyceride Reagent Kit from Pointe Scientific Inc. (Lincoln Park, MI, USA).
Quantitative real-time reverse transcription polymerase chain reaction. Total RNA was isolated from liver and proximal colon from at least four to six mice per experimental condition, and 4 mg of total RNA was reverse transcribed as previously described. 24 Real-time PCR amplification was performed using PowerSYBR qRT-PCR kits (Applied Biosystems, Grand Island, NY, USA) on an Mx3000p analyzer (Stratagene, La Jolla, CA, USA) for primers: TNF-α, zonula occludens-1, occludin, Claudin-1, toll-like receptors (TLR2, TLR4, and TLR9), and 18S (Table 1) . Relative amount of target mRNA was determined using comparative threshold (Ct) method by normalizing target mRNA Ct values to those of 18S and represented as fold change relative to pair-fed/glycerol mice. 24 Statistical analysis. Values shown in all figures represent the mean ± standard error of the mean (n = 4-8 for pair-fed, n = 6-12 for ethanol-fed, and n = 3 experiments for cell culture).
Analysis of variance was performed for data with a normal distribution (e.g. Shapiro-Wilk, Pr < W, P > 0.05) using the general linear models procedure (SAS, Carey, IN, USA). Data were log-transformed as necessary to obtain a normal distribution. Follow-up comparisons were made by least square means testing. P values of less than 0.05 were considered significant.
Results
Tributyrin supplementation mitigated ethanol-induced disruption of TJ protein expression and integrity. Ethanol exposure for 10 days followed by a single gavage exhibited no obvious damaging effect on colonic mucosa morphology in mice (Fig. 1) . As expected per normal histology in proximal colon, an abundance of goblet cells was observed in all groups with counts trending upwards in the EtOH-tributyrin group (Fig. 1b) . Intestinal trefoil factor (ITF) is synthesized and secreted by goblet cells in small and large intestine and is critical in the formation and stabilization of mucus layer. 25 While EtOH treatment depleted ITF mRNA levels in proximal colon, upward trends in expression was noted in ethanoltreated mice supplemented with tributyrin (Fig. 1c) .
Ethanol exposure caused delocalization of TJ in both the proximal colon (claudin-3, occludin, and ZO-1) and ileum (ZO-1 and occludin) (Figs 2a,3a) . Tributyrin co-treatment maintained immunoreactive staining intensity of TJ proteins and co-localization of ZO-1 and occludin to similar patterns visualized in pair-fed mice (Figs 2a,3a) . This protective effect of tributyrin on TJ was found at both mRNA and protein levels in proximal colon, but only protein localization was protected in the ileum as there were no differences in ileal mRNA expression between treatment groups (Figs 2b-d,3b-c).
Butyrate attenuated EtOH-induced redistribution of TJ proteins and decreased TEER in Caco-2 cell monolayers. To test butyrate's direct effect on intestinal epithelial cell integrity disrupted by ethanol, we utilized fully differentiated Caco-2 cell monolayers and evaluated alterations in TJ protein expression and TEER. When cultured without ethanol, TJs were as evidenced by continuous circumferential and co-localized ZO-1 and occludin staining (Fig. 4a) . In contrast, EtOHchallenged (40 mM, 3 h) monolayers demonstrated diminished occludin staining and diminished and diffused fragmentation of ZO-1 staining (Fig. 4a) . Pretreating monolayers with butyrate (5 mM) for 18 h before and then during EtOH exposure attenuated ACCCGAAGAAAGATGGATCG  CATAGTCAGATGGGGGTGGA  TNF-α  CCCTCACACTCAGATCATCTTCT  GCTACGACGTGGGCTACAG  TLR2  TGCTTTCCTGCTGGAGATTT  TGTAACGCAACAGCTTCAGG  TLR4  ATGGCATGGCTTACACCACC  GAGGCCAATTTTGTCTCCACA  TLR9  TCAGCCACAACATTCTCAAGAC  GAGGGTTGCTTCTCACGTCTA  18S ACGGAAGGGCACCACCAGGA CACCACCACCCACGGAATCG this loss in TJ integrity (Fig. 4a) . Tight junction protein expression was coupled with TEER, as ethanol challenge diminished TEER (Fig. 4b ) compared with untreated monolayers. Pretreating the apical compartment with butyrate attenuated TEER reduction in cells exposed to EtOH (Fig. 4b) .
Tributyrin influenced hepatic expression of Toll-like receptors and the inflammatory cytokine TNF-α. In mice only exposed to ethanol, mRNA expression of TLR2, TLR4, and TLR9 was induced, but mice co-treated with tributyrin were protected exhibiting similar mRNA expression as animals not exposed to ethanol (Fig. 5a-c) .
Similarly, protein expression patterns demonstrated with immunohistochemistry in liver of inflammatory cytokine TNF-α trended as the TLRs. Animals co-treated with tributyrin during EtOH exposure exhibited a dampened response compared with those treated with ethanol alone (Fig. 5d,e) . Evaluating the individual mice with positive TNF-α staining in each group, 83% of the ethanol-glycerol mice, 50% of pair-fed mice, and 33% of ethanol-tributyrin mice had positive TNF-α staining ≥ 0.2. Tributyrin and chronic-binge ethanol GA Cresci et al.
Tributyrin mitigated liver injury and induced a differential liver injury pattern in ethanol-exposed mice. Ethanol-exposed mice had elevated plasma ALT levels, as well as neutrophil infiltration, presence of acidophilic bodies indicative of single hepatocyte death, and steatosis assessed histologically (Fig. 6) . However, while tributyrin co-treatment protected against elevated Figure 2 Effects of tributyrin treatment on tight junction protein expression in proximal colon. Mice were treated as described in Figure 1 . Proximal colon was collected and used to prepare RNA or embedded in OCT for histology. (a) Claudin-3 (green), occludin (red), and ZO-1(green) were visualized by immunohistochemistry in sections of proximal colon frozen in OCT. A selected area was cropped and enlarged. All images were acquired using a 40× objective. Images are representative of at least replicate images captured per mouse in four to six mice per treatment group. (b-d) Expression of claudin-1, occludin, and ZO-1 mRNA was detected in the proximal colon of mice using quantitative real-time reverse transcription polymerase chain reaction. Data are the mean ± standard error of the mean. Values with different alphabetical superscripts were significantly different from each other, P < 0.05.
ALT levels, quantitatively, steatosis and neutrophil infiltration was similar between ethanol-treated groups (Fig. 6) . Interestingly, hepatic localization of neutrophilic and acidophilic bodies was impacted by tributyrin; EtOH-only mice exhibited leukocytes and apoptotic hepatocytes predominantly localized to zone 1 (around the portal tract), whereas in localization in ethanoltributyrin mice predominated in zone 3 (around the central vein).
Discussion
Chronic-binge ethanol exposure to mice causes hepatic injury development characteristic of early stage AH. 22 Here, we find that in addition to the negative effects on liver, combined chronic-binge ethanol exposure to mice also impacts intestinal homeostasis, impairing intestinal epithelial cell integrity and barrier function. Importantly, the data presented reveal that prophylactic tributyrin supplementation maintains intestinal barrier function and mitigates certain aspects of liver injury induced by chronic-binge ethanol exposure. While the animal model of chronic-binge ethanol exposure has emerged as a model for early stage acute hepatitis, its effects on intestinal injury are not well defined. 22 The intestinal barrier shields the host from bacterial invasion, or invasion of other microorganisms and their toxins. There is strong evidence for translocation of pathogenic bacteria and/or its byproducts to the liver as contributors to ethanol-induced liver injury progression and infections. 26, 27 Highly dependent upon dietary factors, it is not surprising that chronic ethanol exposure skews gut microbial balance, depletes key metabolites including SCFA, 17 and potentially allows for opportunistic bacterial infection. [3] [4] [5] [6] In humans, dietary changes rapidly and markedly alter fecal microbiota composition. 28 While the current study was not aimed to identify alterations in the gut microbiota or its metabolic byproducts following chronic-binge ethanol exposure, interventions were designed under the assumption that chronic (10 days) ethanol feeding (27% total kcal) would induce gut dysbiosis and skew luminal SCFA ratios. The ability for chronic ethanol exposure to induce gut dysbiosis [2] [3] [4] [5] [6] 17 and shift the luminal distribution of fatty acids 17, 29 has been reported. Further investigations regarding effects of combined chronicbinge ethanol exposure on alterations in gut microbiota and its fermentation byproducts are warranted.
Two important protective features of the intestinal barrier are mucus and TJ protein complexes. While mucus separates intestinal epithelial cells from the luminal environment, TJ seal the paracellular space between epithelial cells. Bacterial penetration of the colonic inner mucus layer by bacteria triggers inflammation. Goblet cells are integral in maintaining inner mucus layer integrity via rapid turnover, 30 and ITF, a member of trefoil factor family and a dominant product of differentiated goblet cells, plays a critical functional role in promoting healing after mucosal damage. 31 Butyrate has a key role in colonic epithelial protection and metabolism and has been shown to stimulate goblet cell quantity and colonic mucus secretion in in vivo models of colitis. 32, 33 The lack of differential mucosal injury between treatment groups following chronic-binge ethanol exposure suggests that beneficial effects of tributyrin on gut-liver protection are not related to goblet cells.
Although pathological damage to colonic mucosa was lacking, we found that chronic-binge ethanol exposure depleted the expression of several key components of the intestinal TJ protein complex. The claudin family and occludin are integral transmembrane proteins that directly interact with cytosolic scaffolding proteins, such as zonula occludens, which in turn anchor the TJ complex to the perijunctional actin cytoskeletal rings in cells. [34] [35] [36] Occludin depletion in intestinal epithelial cells in vitro and in vivo leads to a selective or preferential increase in macromolecule flux, suggesting that occludin plays a crucial role in the maintenance of TJ barrier through the large-channel TJ pathway. 37 Interestingly, despite ethanol's harsh effects on TJ protein localization, tributyrin co-treatment alleviated them. Tributyrin, a prodrug of butyrate, is a structured lipid containing three butyrate molecules esterified to a glycerol backbone. Tributyrin, digested by gastric and pancreatic amylase and lipase 38 exhibits its main effects distal to the duodenum butyrate transporter, and receptor expression is highest in the ileum and colon making these intestinal regions highly likely to benefit from tributyrin supplementation. [39] [40] [41] [42] In our prior work with experimental models that induce gut dysbiosis, tributyrin supplementation protects the intestine. 43, 44 Butyrate induces differentiation in normal intestinal and colon epithelial cells but induces apoptosis in colon cancer cells. 10 Tested in humans as a potential therapy for malignancies and hemoglobinopathy, tributyrin delivery is able to increase plasma butyrate to biologically active levels with minimal demonstrated toxicity. 45 Caco-2 cell monolayer model allows for evaluation of the direct effects of butyrate on protecting intestinal TJ and permeability integrity, in the absence of potential interactions between ethanol and other cells, such as immune and goblet cells, involved with intestinal epithelium homeostasis. Corroborating what we found in vivo, ethanol treatment depleted TJ assembly in Caco-2 cells. Importantly, butyrate co-treatment not only protected against this effect by maintaining TJ protein expression but also preserved TEER, a functional measurement of TJ integrity. Our in vitro data are in line with other studies reporting that SCFA, including butyrate, can enhance TEER in Caco-2 monolayers. 46, 47 In this study, tributyrin protected intestinal integrity during ethanol exposure that was linked with reduced hepatic TLR induction, inflammation and injury. Ethanol-induced intestinal barrier disruption opens the opportunity for pathogen associated molecular patterns to translocate to the liver, activate TLRs, and trigger inflammation contributing to hepatocyte damage. 48, 49 Recently, TLR2 and TLR9 deficient mice showed reduced hepatocellular damage induced by chronic-binge ethanol exposure. 50 These data suggest that tributyrin preservation of the intestinal barrier during chronic-binge ethanol exposure may reduce hepatic ligands for TLRs and protect against hepatic inflammation.
We do not yet know the mechanism(s) by which tributyrin protects from ethanol-induced injury. Ethanol exposure induces histone deacetylase (HDAC) gene alterations in liver and peripheral blood, 51, 52 with increased HDAC gene expression noted in peripheral blood with chronic ethanol exposure 51 and decreased HDAC gene expression following acute ethanol exposure. 51, 52 As a known histone deacetylase inhibitor, tributyrin provision in a rat model of hepatocarinogenesis resulted in lower HDAC activity and increased histone acetylation of the nuclear protein p53 with increased apoptosis and autophagy. 53 Further studies investigating the role of tributyrin and epigenetic regulation in chronic-binge ethanol exposure is warranted. Interestingly, histological localization of inflammatory cells and dying hepatocytes varied between groups of ethanol-fed mice. Richly oxygenated periportal zone 1 is less susceptible to hepatic ischemic injury than zone 3 where oxygen supply is least. Butyrate reduces oxidative stress by influencing intracellular anti-oxidant activity, DNA repair systems or anti-oxidant enzymes. 9 Butyrate protected against insulin resistance and non-alcoholic fatty liver disease reducing hepatic pro-inflammatory parameters via suppression of TNF-α, TLR, and NF-κB activation. 54 Portal butyrate concentrations from endogenous production are reported as high as 64 μM in humans. 55 Therefore, while these data associate intestinal barrier protection by tributyrin with decreased liver injury, they do not exclude that tributyrin may also have a localized hepato-protective effect. Butyrate entry via the portal vein into periportal zone 1 could counteract the pro-oxidant and inflammatory effects of neutrophils noted to be prevalent in this zone in ethanol-only mice. Short-chain fatty acids, acetate, propionate, and butyrate, are agonists with very low potency for several G-protein-coupled receptors (e.g. GPR43, GPR41, and GPR109A). These receptors are expressed on a multitude of tissues and cell types including adipocytes, intestinal epithelial cells, peripheral blood mononuclear cells, and hepatocytes. 56 Activation of these receptors with SCFA induces anti-inflammatory effects. 56, 57 Further investigations determining the role of tributyrin, G-protein-coupled receptors, and chronic-binge ethanol-induced hepatic inflammation are warranted.
In conclusion, tributyrin supplementation protected both the intestinal barrier and liver from injury induced by combined chronic-binge ethanol exposure. As newer treatment options for patients with AH are needed, these data support the concept that tributyrin could represent a novel preventative therapy for protection against mild AH.
